EditorialOmapatrilat- the story of Overture and Octave
References (20)
- http://www.VPI-CME.com accessed June 1...
- et al.
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Lancet
(2002) - et al.
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Lancet
(2002) - et al.
The underreporting of results and possible mechanisms of ‘negative’ drug trials in patients with chronic heart failure
Int J Cardiol
(2001) Consumer involvement in cardiovascular research: ways to combat bias and secrecy
Int J Cardiol
(2000)Heart Failure 99 – the MOXCON story
Int J Cardiol
(1999)- Omapatrilat. Drugs....
- et al.
Omapatrilat versus lisinopril: efficacy and neurohormonal profile in salt-sensitive hypertensive patients
Hypertension
(2001) Omapatrilat – the ups and downs of an exciting but complicated new drug
Int J Cardiol
(2000)- et al.
Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat
J Am Coll Cardiol
(2002)
There are more references available in the full text version of this article.
Cited by (69)
Neprilysin inhibitors: A new hope to halt the diabetic cardiovascular and renal complications?
2017, Biomedicine and PharmacotherapyIatrogenic angioedema: the role of angiotensin converting enzyme inhibitor and angiotensin II receptor blockers
2007, Nephrologie et TherapeutiqueProbing the Requirements for Dual Angiotensin-Converting Enzyme C-Domain Selective/Neprilysin Inhibition
2022, Journal of Medicinal ChemistryExploring the Food and Drug Administration’s review and approval of Entresto (sacubitril/valsartan)
2021, Pharmacology Research and PerspectivesAn evaluation of the fixed-dose combination sacubitril/valsartan for the treatment of arterial hypertension
2020, Expert Opinion on Pharmacotherapy
Copyright © 2002 Elsevier Science B.V. All rights reserved.